{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T05:58:01Z","timestamp":1723269481389},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Aj medichem International, Sri Lanka"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Management of cardiovascular disease (CVD) in patients with haemophilia is extremely challenging. Therefore, knowing the prevalence of CVD and risk factors in this population is imperative.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All consented patients\u2009\u2265\u200918\u00a0years of age attending the haemophilia clinic at a tertiary care centre were recruited to the study. Data were collected using a pretested, investigator administered questionnaire. Seated blood pressure, anthropometric measurements and blood samples were obtained using standard techniques. Lipid profile and fasting plasma glucose were estimated. Prevalence of risk factors for CVD was compared with those of age matched males in the general population. P values\u2009&lt;\u20090.05 were considered significant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the total 109 participants, 92 (84.4%) had haemophilia A. The median age of the study group was 36\u00a0years. Three (2.8%) had at least one cardiovascular disease. There were 10 (9.2%), 30 (27.5%), 13 (11.9%) and 4 (3.7%) participants with diabetes, hypertension, current smoking and obesity (Body Mass Index (BMI)\u2009\u2265\u200930\u00a0kg\/m<jats:sup>2<\/jats:sup>) respectively. 32 (29.4%) and 37 (33.9%) participants had waist circumference\u2009\u2265\u200990\u00a0cm and waist hip ratio\u2009\u2265\u20090.9 respectively. 38 (34.9%) had total cholesterol\u2009\u2265\u2009200\u00a0mg\/dl, 43 (39.5%) had low density lipoprotein (LDL) cholesterol\u2009\u2265\u2009130\u00a0mg\/dl, 25 (22.9%) had triglycerides (TG)\u2009\u2265\u2009150\u00a0mg\/dl and 58 (53.2%) had High density lipoprotein (HDL) cholesterol\u2009&lt;\u200940\u00a0mg\/dl. Diabetes was significantly associated with factor levels below 5% (p\u2009=\u20090.038). BMI, waist circumference and dyslipidaemia in the study were significantly higher compared to the general population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The study signifies an increased prevalence of risk factors for CVD among patients with haemophilia and the need for preventive measures.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02789-1","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T16:02:48Z","timestamp":1659196968000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of cardiovascular diseases and risk factors in adult patients with haemophilia: a cross-sectional study in a tertiary care hospital clinic in Sri Lanka"],"prefix":"10.1186","volume":"22","author":[{"given":"Thamudika","family":"Vithanage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Visaka","family":"Ratnamalala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandana","family":"Wickramaratne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaya","family":"Katulanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chithramali Hasanthika","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"2789_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hae.14046","volume":"26","author":"A Srivastava","year":"2020","unstructured":"Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia. Haemophilia. 2020;26:1\u2013158.","journal-title":"Haemophilia"},{"issue":"3","key":"2789_CR2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1055\/s-0037-1615621","volume":"85","author":"GC White II","year":"2001","unstructured":"White GC II, Rosendaal F, Aledort LM, et al. Definitions in hemophilia: recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85(3):560.","journal-title":"Thromb Haemost"},{"issue":"2","key":"2789_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/bjh.15084","volume":"181","author":"G Ling","year":"2018","unstructured":"Ling G, Nathwani AC, Tuddenham EG. Recent advances in developing specific therapies for haemophilia. Br J Haematol. 2018;181(2):161\u201372.","journal-title":"Br J Haematol"},{"issue":"1","key":"2789_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1056\/NEJMoa1908490","volume":"382","author":"KJ Pasi","year":"2020","unstructured":"Pasi KJ, Rangarajan S, Mitchell N, et al. Multiyear follow-up of AAV5-hFVIII-SQ gene therapy for hemophilia A. N Engl J Med. 2020;382(1):29\u201340.","journal-title":"N Engl J Med"},{"key":"2789_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1055\/s-0034-1381232","volume":"40","author":"M Franchini","year":"2014","unstructured":"Franchini M, Mannucci PM. The history of hemophilia. Semin Thromb Hemost. 2014;40:571\u20136.","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"2789_CR6","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/bjh.15745","volume":"184","author":"S Shapiro","year":"2019","unstructured":"Shapiro S, Makris M. Haemophilia and ageing. Br J Haematol. 2019;184(5):712\u201320.","journal-title":"Br J Haematol"},{"issue":"1","key":"2789_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.thromres.2013.05.007","volume":"132","author":"G Cayla","year":"2013","unstructured":"Cayla G, Morange PE, Chambost H, et al. Management of cardiovascular disease in haemophilia. Thromb Res. 2013;132(1):8\u201314.","journal-title":"Thromb Res"},{"issue":"9438","key":"2789_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, \u00d4unpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case\u2013control study. Lancet. 2004;364(9438):937\u201352.","journal-title":"Lancet"},{"issue":"4","key":"2789_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1365-2516.2010.02463.x","volume":"17","author":"AA Sharathkumar","year":"2011","unstructured":"Sharathkumar AA, Soucie JM, Trawinski B, et al. Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US). Haemophilia. 2011;17(4):597\u2013604.","journal-title":"Haemophilia"},{"key":"2789_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/hae.12339","volume":"20","author":"J Pocoski","year":"2014","unstructured":"Pocoski J, Ma A, Kessler CM, et al. Cardiovascular comorbidities are increased in U.S. patients with haemophilia A: a retrospective database analysis. Haemophilia. 2014;20:472\u20138.","journal-title":"Haemophilia"},{"issue":"11","key":"2789_CR11","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1182\/bloodadvances.2018018226","volume":"2","author":"SL Sood","year":"2018","unstructured":"Sood SL, Cheng D, Ragni M, et al. A cross-sectional analysis of cardiovascular disease in the hemophilia population. Blood Adv. 2018;2(11):1325\u201333.","journal-title":"Blood Adv"},{"issue":"02","key":"2789_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1160\/TH10-07-0460","volume":"105","author":"S Biere-Rafi","year":"2011","unstructured":"Biere-Rafi S, Baarslag MA, Peters M, et al. Cardiovascular risk assessment in haemophilia patients. Thromb Haemost. 2011;105(02):274\u20138.","journal-title":"Thromb Haemost"},{"issue":"3","key":"2789_CR13","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1111\/hae.12596","volume":"21","author":"I Rizwan","year":"2015","unstructured":"Rizwan I, Minuk L, Jackson S, et al. Cardiovascular disease prevalence and relevance in haemophilia: a scoping review. Haemophilia. 2015;21(3):e156\u201366.","journal-title":"Haemophilia"},{"key":"2789_CR14","first-page":"3","volume":"53","author":"DB Jelliffe","year":"1966","unstructured":"Jelliffe DB. The assessment of the nutritional status of the community (with special reference to field surveys in developing regions of the world). Monogr Ser World Health Organ. 1966;53:3\u2013271.","journal-title":"Monogr Ser World Health Organ"},{"key":"2789_CR15","unstructured":"World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8\u201311 December 2008."},{"issue":"7","key":"2789_CR16","first-page":"1391","volume":"72","author":"L Smith","year":"2005","unstructured":"Smith L. New AHA recommendations for blood pressure measurement. Am Fam Phys. 2005;72(7):1391.","journal-title":"Am Fam Phys"},{"key":"2789_CR17","volume-title":"WHO guidelines on drawing blood: best practices in phlebotomy","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. WHO guidelines on drawing blood: best practices in phlebotomy. World Health Organization; 2010."},{"issue":"6","key":"2789_CR18","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206\u201352.","journal-title":"Hypertension"},{"key":"2789_CR19","unstructured":"WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Document number WHO\/NCD\/NCS\/99.2. Geneva: World Health Organization; 1999."},{"key":"2789_CR20","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","volume":"20","author":"American Diabetes Association","year":"1997","unstructured":"American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183\u201397.","journal-title":"Diabetes Care"},{"key":"2789_CR21","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"2789_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"World Health Organization Expert Consultation","year":"2004","unstructured":"World Health Organization Expert Consultation. Appropriate Body Mass Index (BMI) for Asian populations and its implication for policy and intervention strategies. Lancet. 2004;363:157\u201363.","journal-title":"Lancet"},{"issue":"2","key":"2789_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jacl.2018.01.006","volume":"12","author":"P Katulanda","year":"2018","unstructured":"Katulanda P, Dissanayake HA, De Silva SN, et al. Prevalence, patterns, and associations of dyslipidemia among Sri Lankan adults\u2014Sri Lanka Diabetes and Cardiovascular Study in 2005\u20132006. J Clin Lipidol. 2018;12(2):447\u201354.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"2789_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0167-5273(94)90034-5","volume":"46","author":"S Mendis","year":"1994","unstructured":"Mendis S, Ekanayake EM. Prevalence of coronary heart disease and cardiovascular risk factors in middle aged males in a defined population in central Sri Lanka. Int J Cardiol. 1994;46(2):135\u201342.","journal-title":"Int J Cardiol"},{"issue":"10","key":"2789_CR25","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1161\/STROKEAHA.115.010203","volume":"46","author":"T Chang","year":"2015","unstructured":"Chang T, Gajasinghe S, Arambepola C. Prevalence of stroke and its risk factors in urban Sri Lanka: population-based study. Stroke. 2015;46(10):2965\u20138.","journal-title":"Stroke"},{"issue":"5","key":"2789_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/MBC.0b013e328345f582","volume":"22","author":"MY Lim","year":"2011","unstructured":"Lim MY, Pruthi RK. Cardiovascular disease risk factors: prevalence and management in adult hemophilia patients. Blood Coag Fibrinol. 2011;22(5):402\u20136.","journal-title":"Blood Coag Fibrinol"},{"issue":"5","key":"2789_CR27","doi-asserted-by":"publisher","first-page":"E298","DOI":"10.1002\/ajh.24336","volume":"91","author":"TJ Humphries","year":"2016","unstructured":"Humphries TJ, Ma A, Kessler CM, et al. A second retrospective database analysis confirms prior findings of apparent increased cardiovascular comorbidities in hemophilia A in the United States. Am J Hematol. 2016;91(5):E298\u20139.","journal-title":"Am J Hematol"},{"key":"2789_CR28","doi-asserted-by":"publisher","first-page":"2014201","DOI":"10.1155\/2016\/2014201","volume":"2016","author":"RF Barnes","year":"2016","unstructured":"Barnes RF, Cramer TJ, Sait AS, et al. The hypertension of hemophilia is not explained by the usual cardiovascular risk factors: results of a cohort study. Int J Hypertens. 2016;2016:2014201.","journal-title":"Int J Hypertens"},{"issue":"7","key":"2789_CR29","doi-asserted-by":"publisher","first-page":"e12387","DOI":"10.1111\/micc.12387","volume":"24","author":"RF Barnes","year":"2017","unstructured":"Barnes RF, Cramer TJ, Hughes TH, et al. The hypertension of hemophilia is associated with vascular remodeling in the joint. Microcirculation. 2017;24(7):e12387.","journal-title":"Microcirculation"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02789-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02789-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02789-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T16:02:57Z","timestamp":1659196977000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02789-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2789"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02789-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance for this study was obtained by the Ethical Review Committee, Faculty of Medicine, University of Colombo, Sri Lanka (FERCAP accredited) (Ref. number \u2013 EC \u2013 19 - 001) and was conducted in accordance with the principles of the Declaration of Helsinki. Informed written consent was taken from all the volunteer participants of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed written consent for publication without direct personal identification details (such as name and address) was obtained from all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}